Editorial Board: Arch Pharm (11/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202370022
- Publication type:
- Article
Works matching IS 03656233 AND DT 2023 AND VI 356 AND IP 11
Results: 14
1
2
Cover Picture: Arch Pharm (11/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202370021
- Publication type:
- Article
3
2‐Oxoquinoline‐based‐thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300430
- By:
- Publication type:
- Article
4
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300423
- By:
- Publication type:
- Article
5
The anti‐breast cancer potential of indole/isatin hybrids.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300402
- By:
- Publication type:
- Article
6
Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300309
- By:
- Publication type:
- Article
7
Neuroprotective effect of Potentilla reptans L. root in the rat brain global ischemia/reperfusion model.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300363
- By:
- Publication type:
- Article
8
Design and synthesis of benzofuran‐ and naphthalene‐fused thiazinones as antimycobacterial agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300356
- By:
- Publication type:
- Article
9
Potent inhibitors of tumor associated carbonic anhydrases endowed with cathepsin B inhibition.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300349
- By:
- Publication type:
- Article
10
Synthesis of 1,2,4‐triazole and 1,3,4‐oxadiazole derivatives as inhibitors for STAT3 enzymes of breast cancer.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300345
- By:
- Publication type:
- Article
11
The beneficial effects of l‐carnitine and infliximab in methotrexate‐induced hepatotoxicity: Emphasis on Notch1/Hes‐1 signaling.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300312
- By:
- Publication type:
- Article
12
Benzimidazolone‐piperazine/triazole/thiadiazole/furan/thiophene conjugates: Synthesis, in vitro urease inhibition, and in silico molecular docking studies.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300336
- By:
- Publication type:
- Article
13
Repurposing of investigational cancer drugs: Early phase discovery of dengue virus NS2B/NS3 protease inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300292
- By:
- Publication type:
- Article
14
Design, synthesis, and evaluation of new benzimidazole thiourea derivatives as antitumor agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 11, p. 1, doi. 10.1002/ardp.202300269
- By:
- Publication type:
- Article